Kantacid Oral Suspension is a combination antacid formulation containing Aluminium Hydroxide 250 mg, Magnesium Hydroxide 250 mg, and Simethicone 50 mg per dose, designed to provide effective relief from symptoms associated with hyperacidity, indigestion, and gastric discomfort. Aluminium Hydroxide and Magnesium Hydroxide act synergistically to neutralize excess gastric acid, thereby alleviating heartburn, acid reflux, and gastritis-related pain. The inclusion of Simethicone aids in reducing bloating and discomfort caused by excessive gas by promoting the coalescence of gas bubbles, facilitating their expulsion. This oral suspension is indicated for the symptomatic treatment of conditions such as peptic ulcers, gastroesophageal reflux disease (GERD), and dyspepsia. Kantacid Oral Suspension offers a rapid onset of action and is suitable for patients requiring immediate relief from acid-related gastrointestinal symptoms. It is generally well tolerated; however, caution is advised in patients with renal impairment or electrolyte imbalances due to the magnesium and aluminium content. The suspension should be administered as per the prescribed dosage, typically after meals and at bedtime, to optimize therapeutic outcomes. Patients are advised to consult healthcare professionals prior to use, especially if symptoms persist or worsen.